Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine
Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as “the study and design of intelligent agents”. McCarthy invented this term in 1955 and def...
Gespeichert in:
| Veröffentlicht in: | Transfusion and apheresis science Jg. 57; H. 3; S. 422 - 424 |
|---|---|
| Hauptverfasser: | , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Elsevier Ltd
01.06.2018
|
| Schlagworte: | |
| ISSN: | 1473-0502 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as “the study and design of intelligent agents”. McCarthy invented this term in 1955 and defined it as “the science and engineering of making intelligent machines”. The central goals of AI research are reasoning, knowledge, planning, learning, natural language processing (communication), perception and the ability to move and manipulate objects. In fact the multidisplinary AI field is considered to be rather interdisciplinary covering numerous number of sciences and professions, including computer science, psychology, linguistics, philosophy and neurosciences. The field was founded on the claim that a central intellectual property of humans, intelligence-the sapience of Homo Sapiens “can be so precisely described that a machine can be made to simulate it”. This raises philosophical issues about the nature of the mind and the ethics of creating artificial beings endowed with human-like intelligence. Artificial Intelligence has been the subject of tremendous optimism but has also suffered stunning setbacks.
The goal of this narrative is to review the potential use of AI approaches and their integration into pediatric cellular therapies and regenerative medicine. Emphasis is placed on recognition and application of AI techniques in the development of predictive models for personalized treatments with engineered stem cells, immune cells and regenerated tissues in adults and children. These intelligent machines could dissect the whole genome and isolate the immune particularities of individual patient’s disease in a matter of minutes and create the treatment that is customized to patient’s genetic specificity and immune system capability. AI techniques could be used for optimization of clinical trials of innovative stem cell and gene therapies in pediatric patients by precise planning of treatments, predicting clinical outcomes, simplifying recruitment and retention of patients, learning from input data and applying to new data, thus lowering their complexity and costs. Complementing human intelligence with machine intelligence could have an exponentially high impact on continual progress in many fields of pediatrics. However how long before we could see the real impact still remains the big question. The most pertinent question that remains to be answered therefore, is can AI effectively and accurately predict properties of newer DDR strategies?
The goal of this article is to review the use of AI method for cellular therapy and regenerative medicine and emphasize its potential to further the progress in these fields of medicine. |
|---|---|
| AbstractList | Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as "the study and design of intelligent agents". McCarthy invented this term in 1955 and defined it as "the science and engineering of making intelligent machines". The central goals of AI research are reasoning, knowledge, planning, learning, natural language processing (communication), perception and the ability to move and manipulate objects. In fact the multidisplinary AI field is considered to be rather interdisciplinary covering numerous number of sciences and professions, including computer science, psychology, linguistics, philosophy and neurosciences. The field was founded on the claim that a central intellectual property of humans, intelligence-the sapience of Homo Sapiens "can be so precisely described that a machine can be made to simulate it". This raises philosophical issues about the nature of the mind and the ethics of creating artificial beings endowed with human-like intelligence. Artificial Intelligence has been the subject of tremendous optimism but has also suffered stunning setbacks. The goal of this narrative is to review the potential use of AI approaches and their integration into pediatric cellular therapies and regenerative medicine. Emphasis is placed on recognition and application of AI techniques in the development of predictive models for personalized treatments with engineered stem cells, immune cells and regenerated tissues in adults and children. These intelligent machines could dissect the whole genome and isolate the immune particularities of individual patient's disease in a matter of minutes and create the treatment that is customized to patient's genetic specificity and immune system capability. AI techniques could be used for optimization of clinical trials of innovative stem cell and gene therapies in pediatric patients by precise planning of treatments, predicting clinical outcomes, simplifying recruitment and retention of patients, learning from input data and applying to new data, thus lowering their complexity and costs. Complementing human intelligence with machine intelligence could have an exponentially high impact on continual progress in many fields of pediatrics. However how long before we could see the real impact still remains the big question. The most pertinent question that remains to be answered therefore, is can AI effectively and accurately predict properties of newer DDR strategies? The goal of this article is to review the use of AI method for cellular therapy and regenerative medicine and emphasize its potential to further the progress in these fields of medicine. Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as “the study and design of intelligent agents”. McCarthy invented this term in 1955 and defined it as “the science and engineering of making intelligent machines”. The central goals of AI research are reasoning, knowledge, planning, learning, natural language processing (communication), perception and the ability to move and manipulate objects. In fact the multidisplinary AI field is considered to be rather interdisciplinary covering numerous number of sciences and professions, including computer science, psychology, linguistics, philosophy and neurosciences. The field was founded on the claim that a central intellectual property of humans, intelligence-the sapience of Homo Sapiens “can be so precisely described that a machine can be made to simulate it”. This raises philosophical issues about the nature of the mind and the ethics of creating artificial beings endowed with human-like intelligence. Artificial Intelligence has been the subject of tremendous optimism but has also suffered stunning setbacks. The goal of this narrative is to review the potential use of AI approaches and their integration into pediatric cellular therapies and regenerative medicine. Emphasis is placed on recognition and application of AI techniques in the development of predictive models for personalized treatments with engineered stem cells, immune cells and regenerated tissues in adults and children. These intelligent machines could dissect the whole genome and isolate the immune particularities of individual patient’s disease in a matter of minutes and create the treatment that is customized to patient’s genetic specificity and immune system capability. AI techniques could be used for optimization of clinical trials of innovative stem cell and gene therapies in pediatric patients by precise planning of treatments, predicting clinical outcomes, simplifying recruitment and retention of patients, learning from input data and applying to new data, thus lowering their complexity and costs. Complementing human intelligence with machine intelligence could have an exponentially high impact on continual progress in many fields of pediatrics. However how long before we could see the real impact still remains the big question. The most pertinent question that remains to be answered therefore, is can AI effectively and accurately predict properties of newer DDR strategies? The goal of this article is to review the use of AI method for cellular therapy and regenerative medicine and emphasize its potential to further the progress in these fields of medicine. Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as "the study and design of intelligent agents". McCarthy invented this term in 1955 and defined it as "the science and engineering of making intelligent machines". The central goals of AI research are reasoning, knowledge, planning, learning, natural language processing (communication), perception and the ability to move and manipulate objects. In fact the multidisplinary AI field is considered to be rather interdisciplinary covering numerous number of sciences and professions, including computer science, psychology, linguistics, philosophy and neurosciences. The field was founded on the claim that a central intellectual property of humans, intelligence-the sapience of Homo Sapiens "can be so precisely described that a machine can be made to simulate it". This raises philosophical issues about the nature of the mind and the ethics of creating artificial beings endowed with human-like intelligence. Artificial Intelligence has been the subject of tremendous optimism but has also suffered stunning setbacks. The goal of this narrative is to review the potential use of AI approaches and their integration into pediatric cellular therapies and regenerative medicine. Emphasis is placed on recognition and application of AI techniques in the development of predictive models for personalized treatments with engineered stem cells, immune cells and regenerated tissues in adults and children. These intelligent machines could dissect the whole genome and isolate the immune particularities of individual patient's disease in a matter of minutes and create the treatment that is customized to patient's genetic specificity and immune system capability. AI techniques could be used for optimization of clinical trials of innovative stem cell and gene therapies in pediatric patients by precise planning of treatments, predicting clinical outcomes, simplifying recruitment and retention of patients, learning from input data and applying to new data, thus lowering their complexity and costs. Complementing human intelligence with machine intelligence could have an exponentially high impact on continual progress in many fields of pediatrics. However how long before we could see the real impact still remains the big question. The most pertinent question that remains to be answered therefore, is can AI effectively and accurately predict properties of newer DDR strategies? The goal of this article is to review the use of AI method for cellular therapy and regenerative medicine and emphasize its potential to further the progress in these fields of medicine.Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of studies. Leading AI researchers describe the field as "the study and design of intelligent agents". McCarthy invented this term in 1955 and defined it as "the science and engineering of making intelligent machines". The central goals of AI research are reasoning, knowledge, planning, learning, natural language processing (communication), perception and the ability to move and manipulate objects. In fact the multidisplinary AI field is considered to be rather interdisciplinary covering numerous number of sciences and professions, including computer science, psychology, linguistics, philosophy and neurosciences. The field was founded on the claim that a central intellectual property of humans, intelligence-the sapience of Homo Sapiens "can be so precisely described that a machine can be made to simulate it". This raises philosophical issues about the nature of the mind and the ethics of creating artificial beings endowed with human-like intelligence. Artificial Intelligence has been the subject of tremendous optimism but has also suffered stunning setbacks. The goal of this narrative is to review the potential use of AI approaches and their integration into pediatric cellular therapies and regenerative medicine. Emphasis is placed on recognition and application of AI techniques in the development of predictive models for personalized treatments with engineered stem cells, immune cells and regenerated tissues in adults and children. These intelligent machines could dissect the whole genome and isolate the immune particularities of individual patient's disease in a matter of minutes and create the treatment that is customized to patient's genetic specificity and immune system capability. AI techniques could be used for optimization of clinical trials of innovative stem cell and gene therapies in pediatric patients by precise planning of treatments, predicting clinical outcomes, simplifying recruitment and retention of patients, learning from input data and applying to new data, thus lowering their complexity and costs. Complementing human intelligence with machine intelligence could have an exponentially high impact on continual progress in many fields of pediatrics. However how long before we could see the real impact still remains the big question. The most pertinent question that remains to be answered therefore, is can AI effectively and accurately predict properties of newer DDR strategies? The goal of this article is to review the use of AI method for cellular therapy and regenerative medicine and emphasize its potential to further the progress in these fields of medicine. |
| Author | Sniecinski, Irena Seghatchian, Jerard |
| Author_xml | – sequence: 1 givenname: Irena surname: Sniecinski fullname: Sniecinski, Irena email: isniecinsk@aol.com organization: Department of Transfusion Medicine, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA, USA – sequence: 2 givenname: Jerard surname: Seghatchian fullname: Seghatchian, Jerard email: jseghatchian@btopenworld.com organization: International Consultancy in Blood Components Quality/Safety improvement, Audit/Inspection, and DDR Strategies, London, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29784537$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU9vFCEYhznU2D_6ETQcvez0BQbY0RizabSaNPGiZ0KZd_VdZ5gVmCY9-s1l3O2ll3oigef58cLvnJ3EKSJjrwQ0AoS53DUl-ZgDNRLEugHdALQn7Ey0Vq1Agzxl5znvAIQVnXnOTmVn161W9oz92aRCWwrkB06x4DDQD4wB3_IN3011h0efki90h3yKfD8VjGWB54xV4HvsyZdEgeeCI_ex5zSOc0QeahYvPzH5PWH-d5KwZuMxbaxmoIgv2LOtHzK-PK4X7Punj9-uPq9uvl5_udrcrEIrurLqlFkrBaKXWqn-VqIUyhplEQyi9xpQStDC6gDGgjHdumuDVKI1QnQhoLpgbw65-zT9njEXN1JehvQRpzk7Ca202lhjKvr6iM63dUy3TzT6dO8evq0C7w5ASFPOCbcuUKnPmmItggYnwC3FuJ07FuOWYhxoV4uptn5kP1zwlPfh4GH9pjvC5CqxlNVTwlBcP9GTCe8fJYSBIgU__ML7__D_AomBwl0 |
| CitedBy_id | crossref_primary_10_1007_s10815_019_01498_7 crossref_primary_10_1371_journal_pone_0302537 crossref_primary_10_4103_SBVJ_SBVJ_21_25 crossref_primary_10_1007_s12687_023_00678_4 crossref_primary_10_1016_j_imu_2021_100526 crossref_primary_10_3390_biomimetics8050442 crossref_primary_10_1016_j_tibtech_2021_07_002 crossref_primary_10_1016_j_transci_2020_102787 crossref_primary_10_1016_j_transci_2020_102941 crossref_primary_10_1016_j_transci_2020_102785 crossref_primary_10_1007_s00500_021_05972_2 crossref_primary_10_1111_srt_70016 crossref_primary_10_1016_j_arr_2018_11_003 crossref_primary_10_4252_wjsc_v13_i6_521 crossref_primary_10_1007_s10728_025_00536_z crossref_primary_10_1007_s12668_024_01707_3 crossref_primary_10_1016_j_transci_2019_102716 crossref_primary_10_1002_wnan_1673 crossref_primary_10_1038_s41536_022_00271_2 crossref_primary_10_3390_jcm12020438 crossref_primary_10_1016_j_transci_2025_104153 crossref_primary_10_1016_j_ejcped_2024_100197 crossref_primary_10_7759_cureus_49756 crossref_primary_10_1089_omi_2019_0038 crossref_primary_10_3389_frai_2024_1417729 crossref_primary_10_3389_fdmed_2024_1525505 crossref_primary_10_3389_fpsyg_2021_710982 crossref_primary_10_1080_19396368_2024_2445831 crossref_primary_10_1016_j_transci_2019_06_007 |
| Cites_doi | 10.1002/reg2.54 10.1109/JPROC.2013.2262913 10.1016/j.currproblcancer.2015.10.004 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier Ltd Copyright © 2018 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier Ltd – notice: Copyright © 2018 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.transci.2018.05.004 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 424 |
| ExternalDocumentID | 29784537 10_1016_j_transci_2018_05_004 S1473050218301721 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UHS UNMZH Z5R ~G- ~HD AGCQF AGRNS RIG 9DU AAYXX CITATION AACTN AFKWA AJOXV AMFUW NPM 7X8 |
| ID | FETCH-LOGICAL-c419t-93683301d2533db2e2137637e06eeaa50e2205175c0670669894c23146119cce3 |
| ISICitedReferencesCount | 35 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000441487800029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1473-0502 |
| IngestDate | Sun Sep 28 01:23:24 EDT 2025 Wed Feb 19 02:43:51 EST 2025 Sat Nov 29 03:39:48 EST 2025 Tue Nov 18 21:44:04 EST 2025 Fri Jul 18 18:51:51 EDT 2025 Tue Oct 14 19:29:36 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Immune therapy Computational algorithm Computational science Regenerative medicine Artificial intelligence Cancer |
| Language | English |
| License | Copyright © 2018 Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c419t-93683301d2533db2e2137637e06eeaa50e2205175c0670669894c23146119cce3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 29784537 |
| PQID | 2042756766 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | proquest_miscellaneous_2042756766 pubmed_primary_29784537 crossref_citationtrail_10_1016_j_transci_2018_05_004 crossref_primary_10_1016_j_transci_2018_05_004 elsevier_sciencedirect_doi_10_1016_j_transci_2018_05_004 elsevier_clinicalkey_doi_10_1016_j_transci_2018_05_004 |
| PublicationCentury | 2000 |
| PublicationDate | June 2018 2018-06-00 2018-Jun 20180601 |
| PublicationDateYYYYMMDD | 2018-06-01 |
| PublicationDate_xml | – month: 06 year: 2018 text: June 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Transfusion and apheresis science |
| PublicationTitleAlternate | Transfus Apher Sci |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Walker, Enderling (bib0025) 2016; 40 Durant, Lobo, Hammelman, Levin (bib0030) 2016; 28 Acampora, Cook, Rashidi, Vasilakos (bib0015) 2013; 101 Precision medicine initiative. National Institutes of Health web page. Personal communication: Barbara Keremedjiev, American computer and robotics Museum, Bozeman, Montana. (bib0020) 2018; 9 Acampora (10.1016/j.transci.2018.05.004_bib0015) 2013; 101 Walker (10.1016/j.transci.2018.05.004_bib0025) 2016; 40 10.1016/j.transci.2018.05.004_bib0010 Durant (10.1016/j.transci.2018.05.004_bib0030) 2016; 28 10.1016/j.transci.2018.05.004_bib0005 (10.1016/j.transci.2018.05.004_bib0020) 2018; 9 |
| References_xml | – volume: 9 start-page: 5665 year: 2018 end-page: 5690 ident: bib0020 article-title: Converging block chain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare publication-title: Oncotarget – volume: 28 start-page: 78 year: 2016 end-page: 102 ident: bib0030 article-title: Physiological controls of large scale patterning in planaria regeneration; a molecular and computational perspective on growth and form publication-title: Regeneration – reference: Precision medicine initiative. National Institutes of Health web page. – volume: 40 start-page: 68 year: 2016 end-page: 83 ident: bib0025 article-title: From concept to clinic: mathematically informed immunotherapy publication-title: Curr Probl Cancer – reference: Personal communication: Barbara Keremedjiev, American computer and robotics Museum, Bozeman, Montana. – volume: 101 start-page: 2470 year: 2013 end-page: 2494 ident: bib0015 article-title: Survey on ambient intelligence in health care publication-title: Proc Inst Electr Electron Eng – ident: 10.1016/j.transci.2018.05.004_bib0005 – volume: 28 start-page: 78 issue: April (2) year: 2016 ident: 10.1016/j.transci.2018.05.004_bib0030 article-title: Physiological controls of large scale patterning in planaria regeneration; a molecular and computational perspective on growth and form publication-title: Regeneration doi: 10.1002/reg2.54 – volume: 101 start-page: 2470 issue: December (12) year: 2013 ident: 10.1016/j.transci.2018.05.004_bib0015 article-title: Survey on ambient intelligence in health care publication-title: Proc Inst Electr Electron Eng doi: 10.1109/JPROC.2013.2262913 – volume: 40 start-page: 68 year: 2016 ident: 10.1016/j.transci.2018.05.004_bib0025 article-title: From concept to clinic: mathematically informed immunotherapy publication-title: Curr Probl Cancer doi: 10.1016/j.currproblcancer.2015.10.004 – ident: 10.1016/j.transci.2018.05.004_bib0010 – volume: 9 start-page: 5665 issue: January (5) year: 2018 ident: 10.1016/j.transci.2018.05.004_bib0020 article-title: Converging block chain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare publication-title: Oncotarget |
| SSID | ssj0017196 |
| Score | 2.3257391 |
| SecondaryResourceType | review_article |
| Snippet | Artificial Intelligence (AI) reflects the intelligence exhibited by machines and software. It is a highly desirable academic field of many current fields of... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 422 |
| SubjectTerms | Artificial intelligence Cancer Computational algorithm Computational science Immune therapy Regenerative medicine |
| Title | Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1473050218301721 https://dx.doi.org/10.1016/j.transci.2018.05.004 https://www.ncbi.nlm.nih.gov/pubmed/29784537 https://www.proquest.com/docview/2042756766 |
| Volume | 57 |
| WOSCitedRecordID | wos000441487800029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 issn: 1473-0502 databaseCode: AIEXJ dateStart: 20010201 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0017196 providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa2LUJcKt5sgcpI3FYpediJw22FimgFFRIF7S1KnEm7q5Jd7aPqFYkfzkzseFNg1XLgEq2S2Er2--zxODPfMPY6T6uiKuLYk-h-eKLyS6_QufSUSpVOk6Kqmtyqbx-TkxM1GqWfe72fbS7M5UVS1-rqKp39V6jxHIJNqbP_ALfrFE_gbwQdjwg7Hm8F_HDehP80xTg6epsmBX0yxXODOp9bwW_EfjZdUsQQ3r5agAkqt9U7BiTybL4uUBYJDGiXf2AyttDBNqHpcNYIVze9XftQP-kYw2q1aMOec9IxAJJBscbX7fHUY9CujvbRHGpnMb7A2TmajPOx2a09pqTpsrtfEah1XJWdYkVCEYP-tTnYiFRbrkWdCVWYrOU_Jnqz5zA5WNJL6DHF6KlGgtUUM-7gPPveAB2iuyykEZj5TWG7vbTFdsJEpjg37gyPDkfH7mtUEqQmS80--ToT7M1fn4AUpm2fm5Y7m9yZZllzep_tWn-EDw2PHrAe1A_Z3U8WyEfsx5pOvEunt3zIGzJxRyY-rbkjE0cyYQPuyMSJTBwZwA2ZOJGJOzI1V7pk4i2ZHrOv7w9P333wbNkOT4sgXXppFKsI7UYZoitRFiGEAVmxBPwYIM-lD5TcjctWTTliMVUwFRrdDBEHQao1RE_Ydj2t4RnjYRnJIheQQFkIv5KqlLoUUEoZSQWg-0y0_26mraY9lVa5yNrgxUlm8ckIn8yXGeLTZweu2cyIutzUIG6hy9qMZbSxGbLxpobKNbSjyixVb9P0VcuRDKd8AiWvYbpa4E2CijYkcdxnTw153Gu0vNvbeOU5u7celi_Y9nK-gpfsjr5cjhfzfbaVjNS-HQC_AAjE1l0 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Artificial+intelligence%3A+A+joint+narrative+on+potential+use+in+pediatric+stem+and+immune+cell+therapies+and+regenerative+medicine&rft.jtitle=Transfusion+and+apheresis+science&rft.au=Sniecinski%2C+Irena&rft.au=Seghatchian%2C+Jerard&rft.date=2018-06-01&rft.issn=1473-0502&rft.volume=57&rft.issue=3&rft.spage=422&rft_id=info:doi/10.1016%2Fj.transci.2018.05.004&rft_id=info%3Apmid%2F29784537&rft.externalDocID=29784537 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-0502&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-0502&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-0502&client=summon |